Literature DB >> 23764897

HPV16 activates the AIM2 inflammasome in keratinocytes.

M Reinholz1, Y Kawakami, S Salzer, A Kreuter, Y Dombrowski, S Koglin, S Kresse, T Ruzicka, J Schauber.   

Abstract

Human papillomaviruses (HPV) are double-stranded DNA viruses, which selectively infect keratinocytes in stratified epithelia. After an initial infection, many patients clear HPV. In some patients, however, HPV persist, and dysfunctional innate immune responses to HPV infection could be involved in the ineffective clearing of these viruses. In this study, the mechanisms of HPV-induced immune responses in keratinocytes were investigated. Binding of viral DNA leads to AIM2 inflammasome activation and IL-1β release, while IFI16 activation results in IFN-β release. Using immunohistochemistry, AIM2 and IFI16-two recently identified sensors for cytosolic DNA-were also detected in HPV positive skin lesions. CISH stainings further confirmed the presence of cytosolic HPV16 DNA in biopsy samples. Moreover, active IL-1β and cleaved caspase-1 were detected in HPV infected skin, suggesting inflammasome activation by viral DNA. In subsequent functional studies, HPV16 DNA triggered IL-1β and IL-18 release via the AIM2 inflammasome in normal human keratinocytes. Although HPV DNA did not induce IFN-β in keratinocytes, IFN-β secretion was observed when AIM2 was blocked. Meanwhile, blocking of IFI16 increased HPV16 DNA-induced IL-1β, but not IL-18, secretion. These findings suggest crosstalk between IFI16 and AIM2 in the immune response to HPV DNA. In sum, novel aspects concerning HPV-induced innate immune responses were identified. Eventually, understanding the mechanisms of HPV-induced inflammasome activation could lead to the development of novel strategies for the prevention and treatment of HPV infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764897     DOI: 10.1007/s00403-013-1375-0

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  44 in total

Review 1.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.

Authors:  Si Ming Man; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

Review 2.  A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms.

Authors:  Marni S Crow; Aaron Javitt; Ileana M Cristea
Journal:  J Mol Biol       Date:  2015-02-26       Impact factor: 5.469

Review 3.  The nucleic acid-sensing inflammasomes.

Authors:  Tsan Sam Xiao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 4.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

5.  Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.

Authors:  Daeho So; Hyun-Woo Shin; Jiyoung Kim; Mingyu Lee; Jongyun Myeong; Yang-Sook Chun; Jong-Wan Park
Journal:  Oncogene       Date:  2018-05-29       Impact factor: 9.867

Review 6.  Immunobiology and structural biology of AIM2 inflammasome.

Authors:  Bing Wang; Madhurima Bhattacharya; Sayantan Roy; Yuan Tian; Qian Yin
Journal:  Mol Aspects Med       Date:  2020-07-10

7.  The inflammasomes in autoinflammatory diseases with skin involvement.

Authors:  Hans-Dietmar Beer; Emmanuel Contassot; Lars E French
Journal:  J Invest Dermatol       Date:  2014-03-06       Impact factor: 8.551

Review 8.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

Review 9.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

Review 10.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.